These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 756835)

  • 1. The effect of in vivo treatment with (-) delta 1-tetrahydrocannabinol, and other psychoactive drugs on the in vitro uptake of biogenic amines.
    Hershkowitz M
    Adv Biosci; 1978 Jul 22-23; 22-23():351-8. PubMed ID: 756835
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretreatment with delta 1-tetrahydrocannabinol and psychoactive drugs: effects on uptake of biogenic amines and on behavior.
    Hershkowitz M; Szechtman H
    Eur J Pharmacol; 1979 Nov; 59(3-4):267-76. PubMed ID: 230975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotropic agents as regulators of brain monoamine biosynthesis.
    Rayevsky KS; Mineyeva MF
    Acta Physiol Pharmacol Bulg; 1982; 8(1-2):37-42. PubMed ID: 6126995
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between delta 9-tetrahydrocannabinol-induced mouse killing behavior on the rat and the metabolism of monoamines in the brain, particularly the olfactory bulb.
    Shiomi H; Nakahara H; Segawa M; Takagi H
    Jpn J Pharmacol; 1979 Oct; 29(5):803-6. PubMed ID: 231706
    [No Abstract]   [Full Text] [Related]  

  • 5. Early cannabinoid exposure influences neuroendocrine and reproductive functions in male mice: I. Prenatal exposure.
    Dalterio S; Steger R; Mayfield D; Bartke A
    Pharmacol Biochem Behav; 1984 Jan; 20(1):107-13. PubMed ID: 6320227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical notes on the specificity of drugs in the study of metabolism and functions of brain monoamines.
    Garattini S; Mennini T
    Int Rev Neurobiol; 1988; 29():259-80. PubMed ID: 3042665
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of biogenic amines and psychotropic drugs on endogenous prostaglandin biosynthesis in the rat brain homogenates.
    Schaefer A; Komlós M; Seregi A
    Biochem Pharmacol; 1978 Jan; 27(2):213-8. PubMed ID: 623677
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of tetrahydropapaveroline and salsolinol on cerebral monoamine metabolism and their interactions with psychopharmacological drugs.
    Awazi N; Guldberg HC
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar; 306(2):135-46. PubMed ID: 450146
    [No Abstract]   [Full Text] [Related]  

  • 9. Early cannabinoid exposure influences neuroendocrine and reproductive functions in mice: II. Postnatal effects.
    Dalterio S; Steger R; Mayfield D; Bartke A
    Pharmacol Biochem Behav; 1984 Jan; 20(1):115-23. PubMed ID: 6320228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of action of delta 9-tetrahydrocannabinol on body temperature in mice.
    Davies JA; Graham JD
    Psychopharmacology (Berl); 1980; 69(3):299-305. PubMed ID: 6251505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of biogenic amines uptake by imipramine, desipramine, 2 OH-imipramine and 2 OH-desipramine in rat brain.
    Javaid JI; Perel JM; Davis JM
    Life Sci; 1979 Jan; 24(1):21-8. PubMed ID: 763066
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of tetrahydrocannabinol on glucose uptake in the rat brain.
    Miederer I; Uebbing K; Röhrich J; Maus S; Bausbacher N; Krauter K; Weyer-Elberich V; Lutz B; Schreckenberger M; Urban R
    Neuropharmacology; 2017 May; 117():273-281. PubMed ID: 28219717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mazindol on rat brain synaptosomal monoamine uptake.
    Sugrue MF; Mireylees SE
    Biochem Pharmacol; 1978; 27(14):1843-7. PubMed ID: 708465
    [No Abstract]   [Full Text] [Related]  

  • 14. 'Hallucinogenic drugs and central transmitter substances'.
    Leonard BE
    Int J Neurosci; 1972 Jul; 4(1):35-43. PubMed ID: 4348844
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between analgesia and turnover of brain biogenic amines.
    Bensemana D; Gascon AL
    Can J Physiol Pharmacol; 1978 Oct; 56(5):721-30. PubMed ID: 709413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and biochemical effects of chronic delta 9-tetrahydrocannabinol in rats.
    Miczek KA; Dixit BN
    Psychopharmacology (Berl); 1980 Feb; 67(2):195-202. PubMed ID: 6245424
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on brain metabolism of biogenic amines.
    Schacht U; Leven M; Bäcker G
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):77S-87S. PubMed ID: 199222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of (-)-trans-delta 9-tetrahydrocannabinol on regional brain levels and subcellular distribution of monoamines in the rat.
    Taylor DA; Fennessy MR
    Clin Exp Pharmacol Physiol; 1979; 6(5):541-8. PubMed ID: 498594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 1,2-benzisoxazole-3-acetamidoxime on central monoamine neurons in the rat.
    Karasawa T; Furukawa K; Yoshida K; Shimizu M
    Chem Pharm Bull (Tokyo); 1976 Nov; 24(11):2673-85. PubMed ID: 1017104
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory effects of delta-9-tetrahydrocannabinol and other psychotropic drugs on cultured lymphocytes.
    Banchereau J; Desoize B; Léger C; Nahas G
    Adv Biosci; 1978 Jul 22-23; 22-23():129-44. PubMed ID: 756824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.